SARS-CoV-2 diagnostic pipeline
FIND is collating an overview of SARS-CoV-2 tests that are commercially available or in development for the diagnosis of COVID-19.
For all commercialized immunoassays and molecular tests, we have compiled a fully searchable directory. Manufacturer performance data (sensitivity and specificity) are included, where known, alongside data from independent evaluations conducted by FIND, where applicable.
COVID-19 TEST DIRECTORY (Immunoassays, MOLECULAR tests)
For all immunoassays and molecular tests in development, please refer to the list below. This pipeline tracker also has information on other diagnostic tools such as digital solutions and sample collection devices.
The list below was compiled from information submitted voluntarily by test suppliers and is not independently verified. If you have any queries or wish for us to make updates in this pipeline, please contact us.
To know more about the FIND evaluations of submitted SARS-CoV-2 tests, click here. ongoing test evaluations
- AcouSort AB Blood plasma separation using ultrasound (RUO)
Advanced Biological Laboratories SA
DeepChek® 8-Plex CoV-2 Genotyping Assay (by NGS) (RUO)
- Ativa Medical Ativa Enhanced Screen (In development)
- Clear Labs Inc. Clear Dx SARS-CoV-2 Test (US FDA EUA)
- Hemcheck Sweden AB HELGE™: POC-test for rapid and objective detection of hemolysis in blood samples aimed for SARS-CoV-2 antibody testing for prevention of sample rejection in the laboratory (CE-IVD)
- Ingenuity Diagnostics Inc. Home Collection Kit (In development)
- Predigen Inc. HR-PreV (In development)
- RetroVirox Inc. SARS-CoV-2 Pseudovirus assay for Neutralizing Antibodies (RUO)
- Spektrax SPEKTRAX VITE (Surface Enhanced Raman Spectroscopy) (In development)
- The Corona Initiative, PBC Viral Direct Detection At Home Test (In development)
- Trivitron Healthcare Pvt. Ltd ViSure transport kit (CE-IVD)
- Twist Bioscience NGS-based target capture for SARS-CoV-2 detection and screening (In development)